Science and Enterprise

Tag: biotechnology

  • Genetic Signature Validated for Early-Stage Colon Cancer

    ChipDX LLC, an online molecular diagnostics and personalized medicine company in New York, New York, says it discovered and validated a genetic signature for early-stage colon cancer. The company is developing an online screening application for clinicians to more accurately identify risk of recurrence. The study is published in the December issue of the British…

  • Bone Graft Substitute Receives FDA Clearance

    Orthovita Inc., an orthobiologics and biosurgery device developer in Malvern, Pennsylvania, says it received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Vitoss Bioactive Foam-2X bone graft substitute as a non-structural bone void filler for use in the spine, pelvis, and extremities. The company says it expects to launch the…

  • Univ. Develops, Licenses Nanotech Bone Injection Technology

    A bone-healing fluid that can potentially be injected into breaks with a syringe has been licensed from Brown University in Providence, Rhode Island by a biotech startup for further development. The technology, still in an early stage, was developed by Brown engineering professor Thomas Webster, and licensed to Audax Medical Inc., based in Littleton, Massachusetts.…

  • Fraunhofer USA Gets FDA Go-Ahead for H5N1 Vaccine Trial

    Fraunhofer USA Center for Molecular Biotechnology (CMB) in Newark, Delaware says it received approval from the U.S. Food and Drug Administration (FDA) to proceed with the first human clinical trial of its plant-produced H5N1 influenza — avian flu — vaccine. The research institute filed an Investigational New Drug Application for its plant-derived H5N1 vaccine with…

  • Merck To Acquire Biotech for Diabetes Treatment Technology

    Merck & Co. Inc., a global pharmaceutical manufacturer, says it will acquire SmartCells Inc., a biotechnology company in Beverly, Massachusetts developing a glucose responsive insulin formulation for the treatment of diabetes. The SmartCells process was first developed at Massachusetts Institute of Technology by its president, Todd Zion. SmartCells says its technology makes it possible to…

  • Grant Boosts Research Commercialization Group

    The Maryland Proof of Concept Alliance — a consortium of Maryland university research institutions and the U.S. Army Research Laboratory — has received a $5.1 million federal grant to support its work moving research findings from the lab to the marketplace. The Alliance helps researchers through the often tricky and (to the researchers) unfamiliar process…

  • R&D Collaboration to Discover Drugs for River Blindness

    Anacor Pharmaceuticals in Palo Alto California, the University of California San Francisco’s Sandler Center and the Lindsley F. Kimball Research Institute (LFKRI) of the New York Blood Center established a research and development collaboration to discover new therapies to treat river blindness (onchocerciasis). River blindness is a parasitic disease and the second leading cause of…

  • Clinical Data Reported on Parkinson’s Biomarker Candidates

    KineMed Inc., a drug discovery company in Emeryville, California says it recently presented data on a new use of cerebrospinal fluid biomarkers for the monitoring of disease progression and therapeutic interventions in Parkinson’s disease. The company reported the findings at a grant review meeting of the Michael J. Fox Foundation on 1 November 2010 in…

  • Aileron Adds Scripps Chemistry Process for Drug Discovery

    The Scripps Research Institute in San Diego, California and Aileron Therapeutics in Cambridge, Massachusetts said today (30 November) they agreed to add Scripps Research’s molecular chemistry technology known as “click chemistry” to Aileron’s peptide and protein platforms. The agreement provides Aileron exclusive rights to use click chemistry for therapeutics and non-exclusive rights for diagnostics. Click…

  • New Process Replaces Toxic Substances to Make Nanomaterials

    A study by a University of Missouri research team in Columbia has found a method that could replace nearly all of the toxic chemicals required to make gold nanoparticles. The ingredient to replace these toxic substances can be found in nearly every kitchen’s spice cabinet: cinnamon. And the researchers found their discovery could help in…